(Q39773167)

14 September 2017

title

Validation of human ApoB and ApoAI immunoturbidity assays for non-human primate dyslipidemia and atherosclerosis research (English)

1 reference

14 September 2017

1 reference

1 reference

12

Thomas P Roddy

1 reference

14 September 2017

2

Alison M Strack

1 reference

14 September 2017

Zhu Chen

1

1 reference

14 September 2017

Alice C Stefanni

3

1 reference

14 September 2017

Ying Chen

4

1 reference

14 September 2017

Weizhen Wu

5

1 reference

14 September 2017

Yi Pan

6

1 reference

14 September 2017

Olga Urosevic-Price

7

1 reference

14 September 2017

Li Wang

8

1 reference

14 September 2017

Theresa McLaughlin

9

1 reference

14 September 2017

Neil Geoghagen

10

1 reference

14 September 2017

Michael E Lassman

11

1 reference

14 September 2017

Kenny K Wong

13

1 reference

14 September 2017

Brian K Hubbard

14

1 reference

14 September 2017

Amy M Flattery

15

1 reference

14 September 2017

language of work or name

English

0 references

publication date

11 March 2011

1 reference

Journal of Cardiovascular Translational Research

14 September 2017

published in

1 reference

14 September 2017

volume

4

1 reference

14 September 2017

issue

3

1 reference

14 September 2017

page(s)

373-383

1 reference

Increased small low-density lipoprotein particle number: a prominent feature of the metabolic syndrome in the Framingham Heart Study

14 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12265-011-9264-4

Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty-person/ten-country panel.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-011-9264-4

Apolipoprotein A-I versus HDL cholesterol in the prediction of risk for myocardial infarction and stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-011-9264-4

Atorvastatin decreases apolipoprotein C-III in apolipoprotein B-containing lipoprotein and HDL in type 2 diabetes: a potential mechanism to lower plasma triglycerides

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-011-9264-4

Plasma lecithin: cholesterol acyltransferase activity is elevated in metabolic syndrome and is an independent marker of increased carotid artery intima media thickness

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-011-9264-4

Lipid and apolipoprotein ratios: association with coronary artery disease and effects of rosuvastatin compared with atorvastatin, pravastatin, and simvastatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-011-9264-4

LXR ligand lowers LDL cholesterol in primates, is lipid neutral in hamster, and reduces atherosclerosis in mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-011-9264-4

Thyroid hormone beta receptor activation has additive cholesterol lowering activity in combination with atorvastatin in rabbits, dogs and monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-011-9264-4

Assay of total plasma apolipoprotein B concentration in human subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-011-9264-4

Apo B metabolism in the cynomolgus monkey: evidence for post-transcriptional regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-011-9264-4

Lipoprotein receptors and cholesterol homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-011-9264-4

Amino acid sequence of human apoLp-Gln-II (apoA-II), an apolipoprotein isolated from the high-density lipoprotein complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-011-9264-4

Treatment with high-dose simvastatin reduces secretion of apolipoprotein B-lipoproteins in patients with diabetic dyslipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-011-9264-4

Phenotypic predictors of response to simvastatin therapy among African-Americans and Caucasians: the Cholesterol and Pharmacogenetics (CAP) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-011-9264-4

Simvastatin has anti-inflammatory and antiatherosclerotic activities independent of plasma cholesterol lowering

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-011-9264-4

Immunoturbidimetric method for routine determinations of apolipoproteins A-I, A-II, and B in normo- and hyperlipemic sera compared with immunonephelometry

21 January 2018

1 reference

12 December 2020

Reference intervals for plasma apolipoprotein B determined with a standardized commercial immunoturbidimetric assay: results from the Framingham Offspring Study.

1 reference

12 December 2020

Determination of B protein of low density lipoprotein directly in plasma

1 reference

12 December 2020

Cloning and sequencing of bovine apolipoprotein A-I cDNA and molecular evolution of apolipoproteins A-I and B-100

1 reference

12 December 2020

LDL heterogeneity and atherosclerosis in nonhuman primates

1 reference

12 December 2020

Measurment of rhesus monkey (Macaca mulatta) apolipoprotein B in serum by radioimmunoassay: comparison of immunoreactivities of rhesus and human low density lipoproteins

1 reference

12 December 2020

Genetic factors influence the atherogenic response of lipoproteins to dietary fat and cholesterol in nonhuman primates

1 reference

12 December 2020

International Federation of Clinical Chemistry standardization project for measurements of apolipoproteins A-I and B. IV. Comparability of apolipoprotein B values by use of International Reference Material.

1 reference

12 December 2020

A cross-species comparison of the apolipoprotein B domain that binds to the LDL receptor

1 reference

12 December 2020

Decreased human paraoxonase-1 activity in patients with Sjogren's syndrome

1 reference

12 December 2020

Reference intervals for plasma apolipoprotein A-1 determined with a standardized commercial immunoturbidimetric assay: results from the Framingham Offspring Study.

1 reference

12 December 2020

Diet and experimental atherosclerosis in baboons

1 reference

12 December 2020

Evolution of mammalian apolipoprotein A-I and conservation of antigenicity: correlation with primary and secondary structure

1 reference

12 December 2020

Plasma lipoproteins: apolipoprotein structure and function

1 reference

12 December 2020

Nutritional effects on blood lipid and HDL cholesterol concentrations in two subspecies of African green monkeys (Cercopithecus aethiops)

1 reference

12 December 2020

Atherosclerosis in old world monkeys

1 reference

12 December 2020

Immunoturbidimetric assays of apolipoproteins A, AI, AII, and B in serum

1 reference

12 December 2020

Reliability of lipid, lipoprotein, and apolipoprotein measurements.

1 reference

12 December 2020

Distribution of cholesterol and apolipoprotein A-I and A-II in human high density lipoprotein subfractions separated by CsCl equilibrium gradient centrifugation: evidence for HDL subpopulations with differing A-I/A-II molar ratios

1 reference

12 December 2020

Automated determination of apolipoproteins A-I and B with an improved immunoturbidimetric assay using Boehringer Mannheim and Hitachi analyzer systems

1 reference

12 December 2020

International Federation of Clinical Chemistry standardization project for measurements of apolipoproteins A-I and B. II. Evaluation and selection of candidate reference materials

1 reference

12 December 2020

Achieving LDL cholesterol, non-HDL cholesterol, and apolipoprotein B target levels in high-risk patients: Measuring Effective Reductions in Cholesterol Using Rosuvastatin therapY (MERCURY) II

1 reference

12 December 2020

Measurement of apolipoprotein A-I concentration in nonhuman primate serum by enzyme-linked immunosorbent assay (ELISA).

1 reference

12 December 2020

10.1007/S12265-011-9264-4

Identifiers

DOI

1 reference

release_yqoq3evuwnhbtk3m6uaniko5zq

14 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/yqoq3evuwnhbtk3m6uaniko5zq

24 November 2022

mapped directly with Wikidata item

1 reference